Thomas Turalski
Director/Board Member at RYVU THERAPEUTICS S.A.
Net worth: 278 232 $ as of 2024-03-30
Profile
Mr. Thomas Turalski is on the Board of Directors at Ryvu Therapeutics SA. Mr. Turalski was previously employed as a Senior Analyst by Perceptive Advisors LLC, a Senior Analyst by Perceptive Advisors LLC, a Member by Acerta Pharma BV, and a Principal by Exis Capital Management, Inc. He received his undergraduate degree from The Trustees of Columbia University in The City of New York.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
RYVU THERAPEUTICS SA
0.09% | 2022-12-30 | 20,100 ( 0.09% ) | 278 232 $ | 2024-03-30 |
Thomas Turalski active positions
| Companies | Position | Start |
|---|---|---|
| RYVU THERAPEUTICS S.A. | Director/Board Member | - |
Former positions of Thomas Turalski
| Companies | Position | End |
|---|---|---|
Exis Capital Management, Inc.
 Exis Capital Management, Inc. Investment ManagersFinance Founded in 1998 by Adam Sender, Exis Capital Management, Inc. is a hedge fund manager located in New York City | Corporate Officer/Principal | 2007-12-30 |
Perceptive Advisors LLC
 Perceptive Advisors LLC Investment ManagersFinance Perceptive Advisors LLC is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Joseph “Joe” Edelman in 1999. provides investment advice to private funds, separate accounts, and co-investment vehicles. Investors in the client accounts and co-investment vehicles consist primarily of institutional investors, financial institutions, other investment funds, and high-net-worth individuals. | Analyst-Equity | 2004-12-31 |
Acerta Pharma BV
 Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | Corporate Officer/Principal | - |
Perceptive Advisors LLC
Perceptive Advisors LLC Investment ManagersFinance Perceptive Advisors LLC is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Joseph “Joe” Edelman in 1999. provides investment advice to private funds, separate accounts, and co-investment vehicles. Investors in the client accounts and co-investment vehicles consist primarily of institutional investors, financial institutions, other investment funds, and high-net-worth individuals. | Analyst-Equity | - |
Training of Thomas Turalski
| The Trustees of Columbia University in The City of New York | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| RYVU THERAPEUTICS S.A. | Health Technology |
| Private companies | 3 |
|---|---|
Exis Capital Management, Inc.
Exis Capital Management, Inc. Investment ManagersFinance Founded in 1998 by Adam Sender, Exis Capital Management, Inc. is a hedge fund manager located in New York City | Finance |
Perceptive Advisors LLC
Perceptive Advisors LLC Investment ManagersFinance Perceptive Advisors LLC is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Joseph “Joe” Edelman in 1999. provides investment advice to private funds, separate accounts, and co-investment vehicles. Investors in the client accounts and co-investment vehicles consist primarily of institutional investors, financial institutions, other investment funds, and high-net-worth individuals. | Finance |
Acerta Pharma BV
Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | Health Technology |
- Stock Market
- Insiders
- Thomas Turalski
